October 2026
Largest Medical Devices Public Companies in Italy
Benchmark revenue and EBITDA valuation multiples for public comps like
Amplifon, El.En. Group, Svas Biosana, IMD International Medical and Otofarma.
 | Amplifon SpA provides customizable hearing solutions and services through a distribution network of network affiliates, corporate shops, franchises, and shop-in-shops. The company operates in three segments based on geography: the Americas; Europe, the Middle East, and Africa; and Asia-Pacific. It generates the majority of its revenue in the EMEA region. It operates under a variety of brands in these regions, including Amplifon, Beter Horen, Maxtone, and Miracle-Ear. | $14 | -20% | $3.6B | $4.8B | 1.8x | 8.7x | ||
| El.En. SpA is engaged in the research and development, manufacturing, distribution, and sales of laser systems. The company operates in two divisions: medical and industrial. In the medical division, the application of laser is used as a healing treatment for aesthetic, surgical, physiotherapy and dental. Industrial division develops solutions for laser material processing applications through cutting, marking, laser sources and restoration. The company generates the majority of its revenue from the medical division. Geographically, it derives maximum revenue from the Rest of the World. | $18 | +36% | $1.4B | $1.2B | 1.9x | 13.4x | ||
| Svas Biosana SpA operates in the production and distribution of medical device. | $9 | -21% | $47M | $110M | 0.7x | 5.1x | ||
| IMD International Medical Devices SpA is a company manufacturing X-ray medical equipment with a complete range of mobile imaging systems. | $1 | -14% | $26M | $20M | 0.5x | 7.0x | ||
| Otofarma is an Italian hearing-care company that designs and produces hearing aids and related audiology technology. Its devices are fitted to individual hearing needs through a network that includes affiliated pharmacies. The company also provides remote audiology and telemedicine services supported by proprietary software and instrumentation. Patients receive screening, product selection, fitting and follow-up while pharmacy partners extend local access to care. Otofarma earns revenue from device sales, clinical services and technology supplied to its distribution network. The business owns patents covering elements of its medical and information-technology platform. Axon Partners backed Otofarma as the company prepared for a 2025 listing and a new phase of commercial expansion. | $3 | -- | $15M | $10M | 0.6x | 3.8x | ||
| Predict SpA develops innovative healthcare technologies, such as Optip and Mistral, and sells medical diagnostic imaging systems. Its products include Versana Active GE, Optic probe, Versana Balance GE, Voluson S-series, and Vivid T8. | $1 | +10% | $8M | $7M | 0.8x | 7.8x | ||
| Median | $6 | -14% | $36M | $65M | 0.7x | 7.4x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Recent Insights
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.